Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Earum Pharmaceuticals Ltd - 542724 - Notice Of Extra Ordinary General Meeting.

 We hereby inform you that the Board of Directors of the Company has decided to call Extra Ordinary General Meeting of the Company to be held on Saturday, 4th February, 2023 at 12:00 P.M through VC/OAVM. Notice of Extra Ordinary General Meeting of the Company is enclosed. The Company is providing remote E-voting facility to all the shareholders of the Company. The Company has set 28th January, 2023 as the 'Cut-off Date' for taking record of the shareholders of the Company who will be eligible for casting their vote on the resolution to be passed in Extra Ordinary General Meeting for remote E-voting. The remote e-voting period begins on 1st February, 2023 at 9:00 A.M. and ends on 3rd February, 2023 at 5:00 P.M.
11-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 10Th January, 2023

 Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 10th January, 2023 at the Registered Office of the Company, which commenced at 4:00 P.M. and concluded at 4:45 P.M. inter-alia, has: 1. Considered and approved increase in Authorised Share Capital from Rs. 12,35,00,000/- (Rupees Twelve Crores Thirty Five Lakhs) to Rs. 62,35,00,000/- (Rupees Sixty Two Crores Thirty Five Lakhs Only). 2. Decided to hold Extra Ordinary General Meeting of the Members of the Company on Saturday, 4th February, 2023 at 12:00 P.M.
10-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 24Th January, 2023.

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on Tuesday, 24th January, 2023 at 4:00 P.M. at the Registered Office of the Company situated at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060, to consider and approve the alteration in terms of issue of Equity Shares on Rights (Rights Issue).
06-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 10Th January, 2023.

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/01/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th January, 2023 at 3:00 P.M. at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060, to discuss and consider inter alia: 1. Increase in Authorised Share Capital of the Company. 2. Issue of Equity Shares of the Company on Rights basis. Further, pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Thursday, 5th January, 2023 till 48 hours after the conclusion of the meeting.
05-01-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Closure of Trading Window

 Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform you that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from 1st January, 2023 till 48 hours after the declaration and publication of Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2022.
31-12-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures Of Related Party Transactions Pursuant To Regulation 23 (9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2022

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions of the Company for the half year ended 30th September, 2022. Kindly take the same on your record and oblige us. Thanking You
09-11-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has given Newspaper Advertisement on 7th November, 2022 of Unaudited Financial Result for the quarter and Half year ended on 30th September, 2022 in: 1. English Newspaper - The Indian Express Newspaper 2. Regional Language Newspaper (Gujarati) - Financial Express Newspaper Kindly take the same on your record and oblige us.
07-11-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Intimation Of Appointment Of Independent Director Of The Company

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations, we hereby inform you that Mr. Sumitkumar Patel be and is hereby appointed as an Independent Director of the Company with effect from 5th November, 2022. The brief profile of Mr. Sumitkumar Patel is attached. Kindly take the same on your record and oblige us. Thanking You
05-11-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Submission Of Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2022 Along With Limited Review Report

 In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Unaudited Financial Results for the quarter and half year ended on 30th September, 2022 along with Limited Review Report. Please take note of the same and oblige.
05-11-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 5Th November, 2022

 Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 5th November, 2022 at the Registered Office of the Company, which commenced at 3:00 P.M. and concluded at 3:45 P.M. inter-alia, has 1. Consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended on 30th September, 2022 along with Limited Review Report. 2. Appointed Mr. Sumitkumar Patel as an Independent Director of the Company w.e.f. 5th November, 2022. Please take note of the same and oblige.
05-11-2022
Next Page
Close

Let's Open Free Demat Account